Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Debt Issuance
confidence 72%
filed 2026-07-31
Item 8.01
The disclosure announces an amendment to asset sale offers relating to senior secured notes (2028 Notes and 2033 Notes), with the aggregate principal amount increased from $332.2 million to $480.2 million following completion of a term loan prepayment offer. While this involves debt restructuring and refinancing activity rather than issuance of new debt, the material increase in the scope of the asset sale offers and the interconnected debt management activity (term loan prepayment coupled with expanded note offers) constitutes a material financial event affecting the company's capital structure and obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-31
Item 5.07
This Item 5.07 disclosure reports the results of Ralph Lauren Corporation's Annual Meeting of Stockholders held on July 30, 2026. The filing presents voting results for three matters: (i) election of all director nominees (Class A and Class B), (ii) ratification of Ernst & Young LLP as independent auditor, and (iii) advisory approval of named executive officer compensation. The detailed vote tallies for each director and proposal are the core content of the filing, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-31
Item 2.02
OceanFirst Financial Corp. issued a press release on July 30, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing a net loss of $3.0 million ($0.04 per diluted share) for Q2 2026 versus net income of $16.2 million ($0.28 per diluted share) in the prior year period.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-31
Item 8.01
The Board of Directors declared a regular quarterly cash dividend of $0.20 per share, payable on August 21, 2026 to stockholders of record on August 10, 2026, representing the company's 118th consecutive quarterly dividend.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-31
Item 2.02
InTest Corporation issued a press release on July 31, 2026, disclosing preliminary Q2 2026 financial results (revenue ~$35M, gross margin ~40%) and revising full-year 2026 guidance upward to $135–$140M revenue with ~43% gross margin. The disclosure also includes a material weakness in internal controls and a downward revision to Q1 2026 gross margin by 220 basis points ($750K) due to ERP implementation issues at Alfamation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-31
Item 2.02
IES Holdings issued a press release on July 31, 2026 announcing fiscal 2026 third quarter financial results, including revenue of $1,243 million (40% YoY increase), operating income of $178.5 million (60% YoY increase), and net income of $153.0 million (98% YoY increase).
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-07-31
Item 8.01
The Board approved a two-for-one forward stock split effective after August 21, 2026, whereby shareholders of record on August 14, 2026 will receive one additional share for each share held, reflecting management confidence in the business outlook and intended to improve stock liquidity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-31
Item 2.02
Carter's, Inc. issued a press release on July 31, 2026 announcing its financial results for the fiscal quarter ended July 4, 2026, disclosing net sales of $615 million (5% growth), operating income of $140 million, and diluted EPS of $2.87. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-07-31
EX-99.1
The exhibit announces a private placement financing of approximately US$25 million that closed on July 30, 2026, which constitutes a new direct financial obligation (dilutive equity issuance). While the primary focus is the prepayment of existing debt using proceeds from this financing, the financing itself is a material capital-raising event. The exhibit also discloses the company's intention to prepay US$22.375 million in principal plus accrued interest under an existing senior secured loan facility, which represents a material refinancing activity that strengthens the balance sheet and eliminates material debt.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-07-31
Item 5.02
Douglas Stiles, Vice President of Sustainability and Environment, transitioned from his executive management role effective July 28, 2026, and will resign effective August 31, 2026, after three years leading the Yerington Copper Project. He will continue in a limited advisory capacity following his departure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-31
Item 1.01
Sphere 3D entered into an Amended and Restated Sales Agreement with A.G.P. and Maxim Group LLC on July 31, 2026, to conduct at-the-market offerings of up to $10,300,000 in common shares. The company terminated its prior ATM offering agreement under which it had issued 2,172,789 common shares for approximately $5.1 million in gross proceeds.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-31
EX-99.1
The news release announces resolution of longstanding regional water supply disputes between the City of Tehachapi and TCCWD that began in September 2021 and involved multiple legal cases. This settlement removes a material operational and legal impediment to Greenbriar's business in the Tehachapi area, affecting the company's ability to develop sustainable real estate and renewable energy projects. While the settlement itself is not a discrete M&A, litigation, or financial event, it is a material operational milestone that resolves a significant constraint on the company's core business activities.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-31
Item 8.01
The disclosure announces a favorable FDA Advisory Committee vote (10-3) on the clinical meaningfulness of efficacy data from the IGNYTE study for RP1 in advanced melanoma, with an FDA action date of August 2, 2026. This is a material regulatory milestone in the drug development process that would affect investor assessment of the company's lead product candidate's path to approval, but it does not fit the specific categories of earnings release, M&A activity, restatement, auditor change, going concern, impairment, shareholder vote, delisting, bankruptcy, covenant breach, cybersecurity incident, dilutive issuance, material litigation, debt issuance, dividend distribution, or workforce reduction. It is a significant operational/regulatory development rather than a terminal or governance event.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-07-31
This is a press release announcing Buenaventura's second quarter 2026 financial results, including revenue of US$529.0 million, operating income of US$222.2 million, net income of US$237.4 million, and EBITDA of US$277.1 million from direct operations. The disclosure includes detailed production metrics, cash position (US$758.9 million), and year-over-year comparisons, all hallmarks of a quarterly earnings announcement that would materially affect investor assessment of the registrant's financial performance.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-07-31
Ms. Sichuan Zhang resigned as Chief Operating Officer of Hello Group Inc. effective July 31, 2026. The departure of a C-suite executive (COO) is a material event affecting investor assessment of company leadership and operations. The filing explicitly states the resignation was not due to dispute or disagreement, and Ms. Zhang will remain on the board, but the loss of the COO role is a discrete executive departure event.
View raw filing on EDGAR →
6-K
Periodic Quarterly
confidence 95%
filed 2026-07-31
This is Sony Group Corporation's Consolidated Financial Summary for the first quarter ended June 30, 2026, presenting unaudited quarterly financial statements including statements of financial position, income, comprehensive income, changes in stockholders' equity, and cash flows. The document explicitly states it is a periodic quarterly financial report (not a press release announcing results), with full condensed consolidated financial statements prepared under IFRS Accounting Standards. The filing includes forward-looking guidance for the full fiscal year ending March 31, 2027, and notes a recent material event (the 2026 Kumamoto Earthquake on July 28, 2026) whose impact has not yet been quantified.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-31
This is Sony's Q1 FY2026 consolidated financial results announcement, presenting quarterly earnings with detailed segment performance, year-on-year comparisons, and full-year guidance revisions. The document discloses net income of 342.2 billion yen (up 32% YoY), operating income of 476.5 billion yen (up 40% YoY), and updated FY2026 forecasts, making it a material earnings release typical of Item 2.02 disclosure.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-07-31
EX-99.1
This is a press release announcing Magna International's second-quarter 2026 financial results, including sales of $11.0 billion (up 3%), Adjusted EBIT of $677 million (up 16%), and Adjusted EPS of $1.86 (up 29% and a record for Q2). The company also raised its full-year 2026 outlook for Adjusted EBIT Margin, Adjusted EPS, and Free Cash Flow. This is a discrete earnings announcement, not a periodic financial report, and the results are material to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-31
Item 1.01
PSQ Holdings entered into a definitive Asset Purchase Agreement to sell EveryLife, its direct-to-consumer diaper and baby products brand, to FreeHold Brands, LLC for $5.5 million in gross cash proceeds, with expected closing by September 30, 2026. This material disposition represents a strategic refocus on the company's core payments and financial infrastructure business.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-31
EX-99.1
This is a news release dated July 31, 2026, announcing TELUS Corporation's second quarter 2026 financial and operational results. The exhibit discloses Q2 2026 consolidated operating revenues of $4.9 billion, net loss of $1.8 billion (including a $2.1 billion non-cash impairment of TELUS Digital), Adjusted EBITDA of $1.8 billion, and free cash flow of $545 million, along with revised full-year guidance. While the release also announces a dividend reset and strategic priorities, the primary disclosure is the quarterly earnings announcement, which is material to investors assessing the registrant's financial performance and position.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-07-31
EX-99.1
The exhibit is a formal notice from TELUS Corporation's Board of Directors declaring a quarterly cash dividend of $0.1875 Canadian per share on Common shares, payable October 1, 2026 to shareholders of record as of September 10, 2026. This is a routine but material dividend declaration that affects all equity holders and is customarily disclosed in a news release.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-31
EX-99.1
YXT.com announced that it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share after being notified of non-compliance on January 28, 2026. The company changed its ADS ratio from 1:3 to 1:30 to restore compliance. This disclosure directly addresses a delisting risk — the failure to maintain a continued listing standard — and confirms resolution of that risk as of July 30, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 82%
filed 2026-07-31
Item 2.03
The Company entered into a Second Amendment to its Loan and Security Agreement with White Oak Commercial Finance, LLC, modifying the terms of its revolver borrowing base and inventory formula availability. This amendment materially affects the Company's access to liquidity and borrowing capacity by increasing flexibility in accessing revolver borrowings and managing inventory levels.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-31
Item 7.01
Organon disclosed its financial results for Q2 2026 (quarter ended June 30, 2026) via Form 10-Q filing on July 31, 2026, and furnished supplemental non-GAAP financial metrics in this Item 7.01 disclosure. Although the company suspended its customary earnings press release and conference call due to the pending Sun Pharmaceutical merger, the core disclosure—quarterly financial results with reconciled non-GAAP metrics (Adjusted EBITDA, Adjusted EPS, Adjusted Gross Margin, etc.)—constitutes an earnings release. The exhibit provides detailed reconciliations of GAAP to non-GAAP measures for both Q2 and six-month periods, which is material to investors assessing the company's financial performance.
View raw filing on EDGAR →
6-K
Governance Other
confidence 75%
filed 2026-07-31
EX-99.2
Hesai Group disclosed a revision of annual caps for continuing connected transactions with Sharpa (a related party controlled by Co-Founders), increasing the cap from RMB 100 million to RMB 300 million, requiring independent shareholder approval under Hong Kong Listing Rules Chapter 14A.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-31
The 6-K discloses issuance of a Senior Convertible Promissory Note in the principal amount of RMB 15,000,000 (approximately US$2,050,000) with conversion rights into ordinary shares at US$1.50 per share. This is a convertible debt instrument that creates dilutive equity issuance potential, structured as a private placement exempt from registration under the Securities Act of 1933. The conversion feature and equity dilution to existing shareholders make this a material dilutive issuance event.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-31
The 6-K discloses an extension of the closing date for the acquisition of an additional 1.0% Index-Priced Gross Overriding Production Royalty in the Mesabi Project, with closing extended to August 15, 2026 (with further extension option to August 21, 2026). This is a material acquisition activity that would double TMCR's total royalty interest to 2.0% and bring anticipated annual royalty cash flow to approximately $22 million per annum, representing a significant expansion of the Company's asset base and revenue stream.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-31
EX-99.1
The exhibit discloses a strategic collaboration (Memorandum of Agreement) between Instinct Bio's subsidiaries and INVITRX to expand the GENRÊVER cosmetic product line into the U.S. market and develop regenerative medicine initiatives in Indonesia. This is a material operational and strategic partnership that would affect investor assessment of the company's growth trajectory and market expansion plans, but it does not fit the specific event categories of M&A activity (no acquisition/merger/change of control), debt issuance, or other defined event types. The collaboration is material as it represents a significant strategic initiative for international expansion, but the domain is clearly operational/strategic rather than financial, governance, or legal.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-31
EX-99.1
Recon Technology announced a $100 million At-the-Market (ATM) equity offering program under which it may sell Class A ordinary shares to the public through Pacific Century Securities, LLC. ATM offerings are unregistered continuous equity issuances that are dilutive to existing shareholders. The $100 million size and explicit use of proceeds for working capital, capital expenditures, and potential acquisitions make this material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-31
Item 8.01
The Board of Trustees declared a monthly dividend of $0.225 per share payable on September 28, 2026 to shareholders of record as of August 31, 2026. This is a routine but material dividend declaration for a closed-end fund, which is a core distribution to shareholders and would affect investor assessment of the registrant's capital allocation and yield.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-31
Item 8.01
The Board of Trustees declared a monthly dividend of $0.175 per share on common shares, payable September 28, 2026 to shareholders of record as of August 31, 2026. This is a routine but material dividend declaration that affects shareholder returns and is a standard disclosure for a closed-end fund like KKR FS Income Trust Select.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-31
EX-99.1
The news release announces Christian Milau's appointment as President and Chief Executive Officer effective September 30, 2026, and his election to the Board of Directors. While the release also discloses George Burns' retirement as CEO and several other management transitions, the principal disclosed action is Milau's assumption of the CEO role and board seat. The appointment of a new CEO is material to investors' assessment of leadership continuity and strategic direction.
View raw filing on EDGAR →
6-K
Governance Other
confidence 92%
filed 2026-07-31
EX-99.1
The news release announces a board leadership transition: Steven Reid has stepped down as Chair after 13 years of service, Dan Myerson has been appointed Chair, and Patrick Godin has been appointed Lead Independent Director. While this involves executive departures and appointments, the disclosure is framed as a governance succession and renewal process rather than a discrete departure or appointment event. The material nature reflects that Chair succession affects board oversight and governance structure during a period of significant growth (Skouries nearing production, McIlvenna Bay ramping up).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-31
Item 5.07
Kyndryl held its Annual Meeting of Stockholders with four proposals voted on: election of six directors (each receiving approximately 90% support), advisory approval of named executive officer compensation (75% approval), approval of the Amended and Restated 2021 Long-Term Performance Plan increasing share authorization by 7.6 million shares (94% approval), and ratification of PricewaterhouseCoopers LLP as independent auditor (97% approval).
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-07-31
Item 2.02
Pacific Coast Oil Trust issued a press release on July 31, 2026 announcing its monthly net profits interest calculations for May 2026, disclosing operating income, revenues, expenses, and realized prices for its underlying properties. While the disclosure includes material adverse information (no cash distribution, extreme remoteness of future distributions, substantial debt to PCEC, and pending litigation), the core Item 2.02 disclosure is the announcement of monthly financial results and operational metrics, which is characteristic of an earnings_release. The material adverse context (going-concern implications, litigation, asset retirement obligation disputes) does not change the primary classification of the disclosed event itself.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-31
Item 3.01
Traws Pharma received a notification from Nasdaq on July 29, 2026, that it failed to meet the minimum bid price requirement (closing bid below $1.00 per share for 30+ consecutive business days) under Nasdaq Listing Rule 5550(a)(2). The company has 180 days until January 25, 2027, to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the company's continued public listing status.
View raw filing on EDGAR →
6-K
Earnings release
confidence 97%
filed 2026-07-31
EX-99.2
Magna International disclosed Q2 2026 financial results on July 31, 2026, reporting consolidated sales of $11.0B (+3%), Adjusted EBIT of $677M (+16%), Adjusted EBIT margin of 6.2% (+70 bps), and Adjusted EPS of $1.86 (+29%), along with updated full-year 2026 guidance reflecting raised ranges for adjusted EBIT margin, adjusted EPS, and free cash flow.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-31
Item 8.01
QUALCOMM issued 17,826,566 shares of common stock as consideration for the acquisition of Modular Inc in a private placement relying on Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. The filing of a prospectus supplement covering resale of these shares by selling stockholders signals a dilutive equity issuance. This is material as it represents a significant equity dilution to existing shareholders and relates to the previously announced Modular acquisition consideration.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-31
This 8-K discloses a pending material acquisition of Warner Bros. Discovery, Inc. by Paramount Skydance Corporation pursuant to an Agreement and Plan of Merger dated February 27, 2026. The filing includes audited and interim financial statements of WBD, pro forma combined financial statements reflecting the acquisition, and detailed financing arrangements totaling approximately $77.8 billion in merger consideration plus $51.9 billion in acquisition financing. This is a transformative M&A transaction that would materially affect the registrant's capital structure, operations, and financial position.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-07-31
Item 2.02
Mesabi Trust received and reported quarterly royalty payments totaling $1,807,779 from Cleveland-Cliffs Inc. (via Northshore Mining Company) for the period ended June 30, 2026, representing distributions of cash generated from iron ore shipments on trust lands.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-31
Item 5.07
This is a clear disclosure of shareholder vote results from a special meeting held on July 31, 2026. The filing reports voting outcomes on five proposals, including approval of amendments to the Articles of Incorporation (increasing authorized common shares, authorizing preferred and class B common stock, and eliminating super-majority voting rights) and approval of issuance of shares underlying convertible notes. The materiality is evident from the structural changes to the capital structure and voting rights being approved.
View raw filing on EDGAR →
6-K
Governance Other
confidence 75%
filed 2026-07-31
EX-99.1
The exhibit is primarily a governance announcement of a proposed corporate name change from Bit Origin Ltd to SANGRIX INC, subject to shareholder approval at an extraordinary general meeting scheduled for August 11, 2026. While the press release also discusses strategic priorities and an AI infrastructure transaction, the core disclosure is the rebranding initiative and its governance requirements. This is a material governance event as it reflects a significant corporate identity change aligned with the company's strategic direction, though it is contingent on shareholder approval and regulatory registration.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-31
Item 5.02
The filing discloses the appointment of David Wiens as Chief Executive Officer (effective August 17, 2026) and Shane Parrow as President and Chief Operating Officer (effective July 27, 2026), along with their election to the Board of Directors. While the disclosure includes compensatory arrangements (base salary, bonuses, equity awards, and severance terms), the principal disclosed action centers on these two executives taking on significant leadership roles, making exec_appointment the most salient classification. The material nature is evident from the C-suite positions and substantial equity grants ($1.65M and $650K respectively).
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-31
Item 1.01
CenterPoint Energy entered into an Underwriting Agreement on July 30, 2026, to issue $700 million in aggregate principal amount of 6.400% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2058. This is a material creation of a new direct financial obligation through a public debt offering, clearly fitting the debt_issuance category. The substantial principal amount and public nature of the offering make this material to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-31
Item 2.01
Deluxe completed its acquisition of Celero Commerce for approximately $625 million on July 31, 2026, pursuant to an Equity Purchase Agreement and Plan of Merger dated June 17, 2026. The transaction is described as transformative and pivotal, expected to expand Deluxe's payments platform to process over $70 billion in annual gross transaction volume, add 55,000+ merchant relationships, and deliver $15 million in cost synergies.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-31
Item 1.01
Deluxe entered into a Second Amended and Restated Credit Agreement on July 31, 2026, establishing $400 million in revolving credit and $800 million in term loan facilities totaling $1.2 billion in Senior Secured Credit Facilities. The proceeds were used to finance the Celero acquisition and related costs.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-31
Item 8.01
This Item 8.01 disclosure concerns the pending all-stock merger between AvalonBay Communities and Equity Residential (to be named Vivmark Residential), which was entered into on May 20, 2026. The filing updates shareholders on the merger's progress, including the effectiveness of the S-4 registration statement, commencement of proxy mailing, and litigation related to the merger. Although styled as "Other Events," the core disclosure is material M&A activity—specifically the status and supplemental disclosures regarding an announced merger-of-equals transaction.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-07-31
Item 5.02
Mary Mabey, Senior Vice President and General Counsel, agreed to step down effective October 31, 2026. While the disclosure includes compensatory details (pro-rated bonus, continued equity vesting, severance), the principal disclosed action is the departure of a named executive officer from her role. The separation is not disputed and the company explicitly thanks her for service, indicating an orderly transition rather than a contested removal.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-31
Item 3.01
Humacyte received formal notification from Nasdaq on July 31, 2026, that its common stock bid price closed below the $1.00 minimum requirement for 30 consecutive business days, triggering a delisting notice under Nasdaq Listing Rule 5450(a)(1). The company has been granted a 180-calendar-day compliance period (until January 27, 2027) to regain compliance by achieving a closing bid price of $1.00 or more for 10 consecutive business days. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued exchange listing status.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-31
Item 1.01
Northwest Biotherapeutics entered into a $4.9 million convertible promissory note with Yorkville Advisors convertible at a discount to market price, plus a standby equity subscription agreement for up to $50 million of common shares and a warrant for $2 million of shares. These dilutive financing instruments materially affect shareholder ownership.
View raw filing on EDGAR →